UK markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6000+0.0114 (+1.94%)
At close: 04:00PM EDT
0.5979 -0.00 (-0.35%)
After hours: 06:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.13M
Enterprise value 3.85M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)7.23
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.13

Trading information

Stock price history

Beta (5Y monthly) 0.12
52-week change 3-93.75%
S&P500 52-week change 326.14%
52-week high 311.9100
52-week low 30.4390
50-day moving average 30.7754
200-day moving average 31.7222

Share statistics

Avg vol (3-month) 384.78k
Avg vol (10-day) 3102.21k
Shares outstanding 56.88M
Implied shares outstanding 67.18M
Float 84.84M
% held by insiders 129.58%
% held by institutions 15.63%
Shares short (30 Apr 2024) 422.52k
Short ratio (30 Apr 2024) 40.51
Short % of float (30 Apr 2024) 40.45%
Short % of shares outstanding (30 Apr 2024) 40.33%
Shares short (prior month 28 Mar 2024) 445.31k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 331 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Apr 2023
Most-recent quarter (mrq)31 Jan 2024


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-166.84%
Return on equity (ttm)-1,196.26%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.35M
Net income avi to common (ttm)-12.4M
Diluted EPS (ttm)-1.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)282.87k
Total cash per share (mrq)0.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.16
Book value per share (mrq)-0.63

Cash flow statement

Operating cash flow (ttm)-9.08M
Levered free cash flow (ttm)-4.58M